Table 1 Potential CMR indications in hypertensive heart disease

Aggressive, rapidly progressive hypertension

Poor acoustic window

HHD and stroke (to exclude the potential of aortic plaques)

Differential diagnosis of the etiology of LV hypertrophy

Quantification of concurrent aortic valve regurgitation

Evaluation of aortic tree anatomy and exclusion of potential renovascular disease

Differential diagnosis of the etiology and pattern of fibrosis

Documentation of microvascular cardiac disease

Evaluation of treatment

Reduction of the clinical studies cost (smaller patients’ sample for drug validation is needed by CMR)